<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: About 15% of colorectal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> have a deficient DNA mismatch repair phenotype </plain></SENT>
<SENT sid="1" pm="."><plain>The frequency of deficient DNA mismatch repair <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> increases with age due to the hypermethylation of hMLH1 promoter </plain></SENT>
<SENT sid="2" pm="."><plain>The study aimed to determine the prognostic value of deficient DNA mismatch repair phenotype in elderly patients </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN: Mismatch repair phenotype was retrospectively determined by molecular analysis in consecutive resected colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> specimens from patients over 75 years of age from 4 <z:hpo ids='HP_0002664'>Oncology</z:hpo> centres </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: 231 patients (median age: 81, range: 75-100) were enrolled from 2005 to 2008 </plain></SENT>
<SENT sid="5" pm="."><plain>Mean prevalence of deficient DNA mismatch repair phenotype was 22.5%, and 36% for patients over 85 years </plain></SENT>
<SENT sid="6" pm="."><plain>Deficient DNA mismatch repair status was significantly associated with older age, female sex, proximal colon primary and high grade <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>For stage II <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> no deficient DNA mismatch repair <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> had a recurrence at end of follow-up compared to 17% for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> with proficient phenotype </plain></SENT>
<SENT sid="8" pm="."><plain>The proficient phenotype status was significantly associated with worse age-adjusted overall survival [HR 2.60; 95% CI 1.05-6.44; p=0.039] </plain></SENT>
<SENT sid="9" pm="."><plain>For stage III <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> a trend for less recurrence was observed for deficient DNA mismatch repair phenotype (16%) compared to proficient phenotype (36%) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: deficient DNA mismatch repair phenotype is a prognostic factor in stage II <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumour</z:e> in elderly patients </plain></SENT>
<SENT sid="11" pm="."><plain>Our results suggest that mismatch repair phenotype should be taken in consideration for adjuvant chemotherapy decision in elderly patients </plain></SENT>
</text></document>